Literature DB >> 22300770

Increased CD34+/KDR+ cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjects.

Emmanouil Papasavvas1, Priscilla Hsue, Griffin Reynolds, Maxwell Pistilli, Aidan Hancock, Jeffrey N Martin, Steven G Deeks, Luis J Montaner.   

Abstract

BACKGROUND: Endothelial progenitor cells (EPCs) are involved in the endothelium repair. Low circulating EPC levels are predictive of cardiovascular events in HIV-negative subjects. The impact of HIV infection on EPCs, and the role of EPCs in HIV-associated cardiovascular disease, is not known. We hypothesized that circulating EPCs would be inversely associated with carotid artery intima-media thickness (c-IMT) changes in HIV-infected subjects.
METHODS: EPCs (CD34(+)/KDR(+), CD133(+)/KDR(+) and CD34(+)/CD133(+)/KDR(+)) were defined retrospectively by flow cytometry in cryopreserved peripheral blood mononuclear cells collected longitudinally from 66 chronic HIV-infected subjects and cross-sectionally from 50 at-risk HIV-negative subjects. The HIV-infected subjects participated in the Study of the Consequences of the Protease Inhibitor Era (SCOPE) cohort, were receiving antiretroviral therapy (59/66) and had two sequential measurements of c-IMT 1 year apart. Two distinct groups of HIV-infected subjects were identified a priori: rapid c-IMT progressors (subjects with rapid c-IMT progression, n=13, Δc-IMT>0.2 mm) and slow c-IMT progressors (subjects with slow or no c-IMT progression, n=53, Δc-IMT<0.2 mm).
RESULTS: Although cryopreservation reduced sensitivity of detection, EPC frequency in HIV-infected subjects was still significantly higher compared to at-risk HIV-negative subjects (CD34(+)/KDR(+); P=0.01) and correlated positively with CD4(+) T-cell count (CD34(+)/KDR(+), r=0.27; P=0.03). No association was found between the change of EPC frequencies over time (ΔEPC) and Δc-IMT or between EPC frequencies and c-IMT or Δc-IMT.
CONCLUSIONS: The lack of an association between EPCs and c-IMT in our cohort does not support HIV-associated reductions in EPC frequency as a cause of accelerated atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22300770      PMCID: PMC3362125          DOI: 10.3851/IMP2013

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  27 in total

1.  Circulating endothelial progenitors--cells as biomarkers.

Authors:  Anthony Rosenzweig
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

2.  Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis.

Authors:  Gilles Chironi; Laurence Walch; Marie-Gabrielle Pernollet; Jérôme Gariepy; Jaime Levenson; Francine Rendu; Alain Simon
Journal:  Atherosclerosis       Date:  2006-04-18       Impact factor: 5.162

3.  Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population.

Authors:  Gian Paolo Fadini; Anna Coracina; Ilenia Baesso; Carlo Agostini; Antonio Tiengo; Angelo Avogaro; Saula Vigili de Kreutzenberg
Journal:  Stroke       Date:  2006-07-27       Impact factor: 7.914

4.  Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals.

Authors:  Mervin C Yoder; Laura E Mead; Daniel Prater; Theresa R Krier; Karim N Mroueh; Fang Li; Rachel Krasich; Constance J Temm; Josef T Prchal; David A Ingram
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

5.  Circulating endothelial progenitor cells and cardiovascular outcomes.

Authors:  Nikos Werner; Sonja Kosiol; Tobias Schiegl; Patrick Ahlers; Katrin Walenta; Andreas Link; Michael Böhm; Georg Nickenig
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

6.  Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy.

Authors:  Gian Paolo Fadini; Saverio Sartore; Mattia Albiero; Ilenia Baesso; Ellen Murphy; Mirko Menegolo; Franco Grego; Saula Vigili de Kreutzenberg; Antonio Tiengo; Carlo Agostini; Angelo Avogaro
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-07-20       Impact factor: 8.311

7.  Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men.

Authors:  Robert C Kaplan; Lawrence A Kingsley; Stephen J Gange; Lorie Benning; Lisa P Jacobson; Jason Lazar; Kathryn Anastos; Phyllis C Tien; A Richey Sharrett; Howard N Hodis
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

8.  Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.

Authors:  Francesca J Torriani; Lauren Komarow; Robert A Parker; Bruno R Cotter; Judith S Currier; Michael P Dubé; Carl J Fichtenbaum; Mariana Gerschenson; Carol K C Mitchell; Robert L Murphy; Kathleen Squires; James H Stein
Journal:  J Am Coll Cardiol       Date:  2008-08-12       Impact factor: 24.094

9.  Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption of antiretroviral therapy.

Authors:  Emmanouil Papasavvas; Livio Azzoni; Maxwell Pistilli; Aidan Hancock; Griffin Reynolds; Cecile Gallo; Joe Ondercin; Jay R Kostman; Karam Mounzer; Jane Shull; Luis J Montaner
Journal:  AIDS       Date:  2008-06-19       Impact factor: 4.177

10.  Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors.

Authors:  Jamie Case; Laura E Mead; Waylan K Bessler; Daniel Prater; Hilary A White; M Reza Saadatzadeh; Janak R Bhavsar; Mervin C Yoder; Laura S Haneline; David A Ingram
Journal:  Exp Hematol       Date:  2007-07       Impact factor: 3.084

View more
  6 in total

Review 1.  HIV-1-Associated Atherosclerosis: Unraveling the Missing Link.

Authors:  Alison Kearns; Jennifer Gordon; Tricia H Burdo; Xuebin Qin
Journal:  J Am Coll Cardiol       Date:  2017-06-27       Impact factor: 24.094

Review 2.  Initiation of antiretroviral therapy at high CD4 cell counts: does it reduce the risk of cardiovascular disease?

Authors:  Chris T Longenecker; Virginia A Triant
Journal:  Curr Opin HIV AIDS       Date:  2014-01       Impact factor: 4.283

3.  Low Levels of Endothelial Progenitor Cells and Their Association with Systemic Inflammation and Monocyte Activation in Older HIV-Infected Men.

Authors:  Sophie Seang; Theodoros Kelesidis; Diana Huynh; Sangeun Park; Ardis A Moe; Judith S Currier; Jordan E Lake
Journal:  AIDS Res Hum Retroviruses       Date:  2018-01       Impact factor: 2.205

4.  A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study.

Authors:  Laura Fernández-Sender; Carlos Alonso-Villaverde; Anna Rull; Esther Rodríguez-Gallego; Marta Riera-Borrull; Anna Hernández-Aguilera; Jordi Camps; Raúl Beltrán-Debón; Gerard Aragonès; Javier A Menendez; Jorge Joven
Journal:  AIDS Res Ther       Date:  2013-05-09       Impact factor: 2.250

5.  Evaluation of endothelial function and subclinical atherosclerosis in patients with HIV infection.

Authors:  F Arnaiz de Las Revillas; J A Parra; C Armiñanzas; C Fariñas-Alvarez; V Gonzalez-Quintanilla; E Palacios; C Gonzalez-Rico; M Gutiérrez-Cuadra; A Oterino; M C Fariñas
Journal:  Sci Rep       Date:  2021-09-16       Impact factor: 4.379

6.  The CD133+ Stem/Progenitor-Like Cell Subset Is Increased in Human Milk and Peripheral Blood of HIV-Positive Women.

Authors:  Jacqueline María Valverde-Villegas; Mar Naranjo-Gomez; Mélusine Durand; David Rutagwera; Anne-Sophie Bedin; Chipepo Kankasa; Ségolène Debiesse; Nicolas Nagot; Edouard Tuaillon; Philippe Van de Perre; Jean-Pierre Molès
Journal:  Front Cell Infect Microbiol       Date:  2020-09-24       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.